Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society
Email not displaying correctly? View it in your browser.
National MS eNEWS - November 2013
How what we've learned is changing lives

Live webcast: What we’ve learned is changing lives

On Thursday, Dec 5, join a panel of MS experts as they discuss promising research to repair MS damage and what it means to people living with MS. The Society’s Chief Advocacy, Services and Research Officer, Dr. Tim Coetzee, will be joined by Drs. Ben Barres (Stanford, nerves and myelin-making cells), Barancik-prize winner Jonah Chan (UCSF, myelin repair) and Rhonda Voskuhl (UCLA, sex hormones and nerve protection).

         Sign Up Now

Related: Early studies begin on new oral treatment for spasticty while Italian researchers assess the ability of skin tissue to repair MS.

Connect to discuss this and other MS research


Medicate Part D

Enroll now thru Dec 7


Flu Vaccines

Are they safe for you?

 Donate Now


facebook twitter youtube flickr linkedin

38 New MS Research ProjectsNew Society-funded research

The National MS Society has just launched 38 new MS research projects, with multiyear commitments totaling $19.4 million. This commitment is the latest in the Society’s relentless research effort to find solutions for everyone affected by MS.

Read more now


The Hughes Sisters Study seeks relatives of people with MS

Want to help end MS? Researchers are now recruiting 5,000 people who have at least one first-degree relative with a diagnosis of MS for a study testing a new method of identifying people at risk for MS. The results may influence the design of strategies to prevent MS in the future.

Learn more


More MS News

Nov 13: Results from FDA advisory panel meeting to consider approval of Lemtrada™ (alemtuzumab)

Oct 30: Can measuring walking speed help to track MS progression?

Read more about this and other recent reports

This communication is partially sponsored through the generous support of
Biogen Idec; Genzyme, a Sanofi company; Novartis Pharmaceuticals Corporation; and Teva Neuroscience, Inc.
MS Active Source Genzyme, a Sanofi company Novartis Teva Neuroscience, Inc.
Join a Walk MS Event       Join a Bike MS Event      Shop at the Society Store

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our website.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to   .
To ensure that you continue to receive our emails, please add us to your address book.